Finance

Lists
Why is JAGSNPHARM down 2,16%?
Dive Deeper
JAGSNPHARM:NSE
Jagsonpal Pharmaceuticals Ltd
219,01 INR
-2,16%
(-4,84) 1D
15 ოქტ, 15:30:01 GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for JAGSNPHARM...
Open
224,60 INR
High
224,60 INR
Low
218,20 INR
Mkt. cap
14,47 მლრდ.
Avg. vol.
419,89 ათ.
Volume
44,52 ათ.
Dividend
1,14%
Quarterly dividend
0,63 INR
Ex-dividend date
4 სექ. 2026
P/E ratio
32,53
52-wk high
264,50 INR
52-wk low
155,00 INR
EPS
6,73 INR
Shares outstanding
26,20 მლნ.
No. of employees
1 ათ.
Open
224,60 INR
High
224,60 INR
Low
218,20 INR
Mkt. cap
14,47 მლრდ.
Avg. vol.
419,89 ათ.
Volume
44,52 ათ.
Dividend
1,14%
Quarterly dividend
0,63 INR
Ex-dividend date
4 სექ. 2026
P/E ratio
32,53
52-wk high
264,50 INR
52-wk low
155,00 INR
EPS
6,73 INR
Shares outstanding
26,20 მლნ.
No. of employees
1 ათ.
News stories
From web sources and news partners
The Spokesman-Review
The Spokesman-Review
·
21 წუთის წინ
S&P 500 ends higher as traders shift from AI to healthcare
Investor's Business Daily
Investor's Business Daily
·
1 საათის წინ
Anthropic Value Report Hits Tech Futures; Tesla Touts Roadster
About Jagsonpal Pharmaceuticals Ltd
CEO-
Employees1,3 ათ.
Founded1978
Headquarters-
SectorPharmaceutical industry
Last report
30 ივლ. 2026
Fiscal period
Q1 2027
- / -
Revenue / Est. (INR)
822,32 მლნ. / -
Fiscal Q1 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Revenue
Net income
All values in INR
სექ. 2025
დეკ. 2025
მარ. 2026
ივნ. 2026
Revenue
744,65 მლნ.
729,45 მლნ.
642,03 მლნ.
822,32 მლნ.
Cost of goods sold
272,28 მლნ.
264,53 მლნ.
249,67 მლნ.
286,24 მლნ.
Cost of revenue
272,28 მლნ.
264,53 მლნ.
249,67 მლნ.
286,24 მლნ.
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
165,46 მლნ.
172,95 მლნ.
397,81 მლნ.
227,78 მლნ.
Operating expense
331,89 მლნ.
326,10 მლნ.
303,96 მლნ.
385,10 მლნ.
Total operating expenses
604,17 მლნ.
590,63 მლნ.
553,63 მლნ.
671,34 მლნ.
Operating income
140,48 მლნ.
138,82 მლნ.
88,40 მლნ.
150,98 მლნ.
Other non operating income
30,27 მლნ.
29,75 მლნ.
-87,71 მლნ.
28,33 მლნ.
EBT including unusual items
168,10 მლნ.
145,21 მლნ.
117,56 მლნ.
176,80 მლნ.
EBT excluding unusual items
168,10 მლნ.
166,00 მლნ.
117,56 მლნ.
176,80 მლნ.
Income tax expense
42,36 მლნ.
35,70 მლნ.
29,94 მლნ.
44,91 მლნ.
Effective tax rate
25,20%
24,59%
25,47%
25,40%
Other operating expenses
126,28 მლნ.
126,45 მლნ.
-82,94 მლნ.
135,90 მლნ.
Net income
125,74 მლნ.
109,51 მლნ.
87,62 მლნ.
131,89 მლნ.
Net profit margin
16,89%
15,01%
13,65%
16,04%
Earnings per share
-
-
-
-
Interest and investment income
-
-
117,43 მლნ.
-
Interest expense
-2,65 მლნ.
-2,57 მლნ.
-560,00 ათ.
-2,51 მლნ.
Net interest expenses
-2,65 მლნ.
-2,57 მლნ.
116,87 მლნ.
-2,51 მლნ.
Depreciation and amortization charges
23,86 მლნ.
23,86 მლნ.
23,19 მლნ.
21,42 მლნ.
EBITDA
164,18 მლნ.
155,55 მლნ.
108,00 მლნ.
174,59 მლნ.
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google აპები